About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COVID-19 and Multiple Sclerosis Disease Modifying Therapies

COVID-19 and Multiple Sclerosis Disease Modifying Therapies

NCT04863586·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Nottingham University Hospitals NHS Trust

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Age 18 or above
Diagnosed with MS
Received treatment with a DMT

The record

StatusUnknown

PhaseNo phase

Taking part14,240

StartedApr 2021

UpdatedApr 28, 2021

Conditions

Covid19 Multiple Sclerosis

Where1

Nottingham University Hospitals NHS Trust
Nottingham, Nottinghamshire, United Kingdom